{
    "code": 0,
    "data": [
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffde32c0-d5d8-466f-9072-b02905c1934a.pdf",
            "news_date": "2026-02-09 17:06:54"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval for Zoledronic Acid Injection 4 mg/ 100 mL (0.04 mg/mL) Single-Dose Bags",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92c23ce7-d6cb-40d2-b5ee-2511ed5b9c8b.pdf",
            "news_date": "2026-02-06 11:13:46"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "news_id": "00c458ff-99e4-4df1-b75b-11dc69398eee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=937f9d7d-d366-4170-931d-281f106b2a1b.pdf",
            "news_date": "2026-02-03 17:03:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=937f9d7d-d366-4170-931d-281f106b2a1b.pdf",
            "news_date": "2026-02-03 17:03:15"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investors Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea45e9a5-3edc-43e5-97c2-d3475d8bd90f.pdf",
            "news_date": "2026-02-01 05:31:30"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Retirement of Mr. Satnam Singh Loomba as Chief Operating Officer of the Company from the close of business hours of March 31 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d30fb2aa-ce79-4dee-8596-91580b803497.pdf",
            "news_date": "2026-01-29 16:13:18"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of News Paper Publication on Q3FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c1545a5-0b75-4b57-a205-1ef04a413fa0.pdf",
            "news_date": "2026-01-29 16:06:55"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q3FY26 Earnings Conference Call Audio recording",
            "news_id": "fe13bcd5-e3ad-438a-b128-c30fa47ddb36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1de4697-ae87-46fd-b9d9-9b94a25b7a43.pdf",
            "news_date": "2026-01-28 21:16:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q3FY26 Earnings Conference Call Audio recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1de4697-ae87-46fd-b9d9-9b94a25b7a43.pdf",
            "news_date": "2026-01-28 21:16:44"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY26 Financial Results",
            "news_id": "f480fd25-8fec-434a-9b01-3e64666b0d78",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4106eb-8744-48f5-b7e3-2fb0d09d8755.pdf",
            "news_date": "2026-01-28 17:28:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4106eb-8744-48f5-b7e3-2fb0d09d8755.pdf",
            "news_date": "2026-01-28 17:28:44"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Q3FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4994aa39-af75-4219-b12e-d1588e4214ea.pdf",
            "news_date": "2026-01-28 17:23:37"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 28 2026",
            "news_body": "Outcome of Board Meeting held on January 28 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcc28cc8-1497-409a-8e10-23882b41067b.pdf",
            "news_date": "2026-01-28 17:18:03"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited Financial results for the quarter and nine months ended December 31 2025",
            "news_id": "16f6db79-9412-4fc2-8b53-41c6ccfd0478",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abbfef19-482c-47db-b669-28e470f45bbe.pdf",
            "news_date": "2026-01-28 17:14:57",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited Financial results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abbfef19-482c-47db-b669-28e470f45bbe.pdf",
            "news_date": "2026-01-28 17:14:57"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3168f927-a928-4353-a266-a0c94949f18f.pdf",
            "news_date": "2026-01-13 17:27:51"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Q3FY26 Earnings Call Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbcd89c-bce1-4cac-85ef-8f9c0ae48afb.pdf",
            "news_date": "2026-01-09 12:29:50"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37ad1418-49ef-414e-a91a-2f6845c5d645.pdf",
            "news_date": "2026-01-09 12:24:23"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval from USFDA for Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6942fb54-d6d3-4f3f-99d0-8a604a29aa4e.pdf",
            "news_date": "2026-01-07 15:41:27"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39b01aa6-1df4-4781-a9c2-d8212a2810bb.pdf",
            "news_date": "2025-12-26 12:46:08"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=925673fd-9a86-425c-b391-b91ae77044d5.pdf",
            "news_date": "2025-12-12 15:40:06"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b8734eb-579a-494b-9c2c-4128e9d84cbf.pdf",
            "news_date": "2025-12-11 17:42:08"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fb8b6da-4323-461d-89ff-8f19677f5dba.pdf",
            "news_date": "2025-12-08 17:04:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Investor meets",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdca2a90-b8e6-4373-abd5-5bb1324a7ea7.pdf",
            "news_date": "2025-11-13 17:12:59"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2FY26 Earnings Call Transcript",
            "news_id": "f9d82f46-7183-42aa-a825-f156e4240c6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b06a13-ec55-4396-9096-329d957bcec0.pdf",
            "news_date": "2025-11-07 16:42:06",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b06a13-ec55-4396-9096-329d957bcec0.pdf",
            "news_date": "2025-11-07 16:42:06"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Q2FY26 Results News Paper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d46eb96-d159-41c9-9b92-259e1f86e525.pdf",
            "news_date": "2025-11-04 15:01:15"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q2FY26 Earnings Call Audio Recording",
            "news_id": "c1a668fb-fb6d-4e8c-a054-a1eae3278c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff0bb70b-d3e0-48ec-befc-dcb93e87e690.pdf",
            "news_date": "2025-11-03 21:24:11",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q2FY26 Earnings Call Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff0bb70b-d3e0-48ec-befc-dcb93e87e690.pdf",
            "news_date": "2025-11-03 21:24:11"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY26 Financial Results",
            "news_id": "0fa3d373-bd4f-4c71-9c42-60424bd0cdad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90359eb7-19e0-41c8-b0b9-e9c3541f0a24.pdf",
            "news_date": "2025-11-03 16:48:19",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90359eb7-19e0-41c8-b0b9-e9c3541f0a24.pdf",
            "news_date": "2025-11-03 16:48:19"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Q2FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68b46acc-b68e-4d97-bfc2-cc21d2282773.pdf",
            "news_date": "2025-11-03 16:45:05"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=909c04b1-0d78-4bf5-a114-86b769ff5d7d.pdf",
            "news_date": "2025-11-03 16:37:54"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "0e457bbc-7068-47a5-a005-849dfc0c3119",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecaea78b-a751-4978-a469-e3be6ffd5e17.pdf",
            "news_date": "2025-11-03 16:34:55",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecaea78b-a751-4978-a469-e3be6ffd5e17.pdf",
            "news_date": "2025-11-03 16:34:55"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Analyst Meet Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ef9b45a-1007-460b-a54f-b8673f105e11.pdf",
            "news_date": "2025-10-31 17:11:55"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Q2FY26 Earnings Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70e325c2-0384-4bf5-afdc-e346b4c085bc.pdf",
            "news_date": "2025-10-17 16:11:32"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fb5d74e-e1fe-401a-99a8-5bb88b9eaf0f.pdf",
            "news_date": "2025-10-17 16:04:02"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2739b5b4-e3b9-4c20-a29d-4c76d9fc8359.pdf",
            "news_date": "2025-10-14 16:22:47"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading Window Closure for the quarter and half year ending on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e5c3f00-a72c-4d23-ad5c-cbb7821129eb.pdf",
            "news_date": "2025-09-30 12:10:07"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet on September 22 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a8e3e8b-62be-43be-b2b9-1a5213795018.pdf",
            "news_date": "2025-09-17 17:49:43"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e10012a-7549-4958-83de-b10032759c17.pdf",
            "news_date": "2025-09-08 15:03:08"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3851760-adbd-4f37-ac8f-bfebcf7dd562.pdf",
            "news_date": "2025-08-28 22:17:18"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Reappointment of Mr. Essaji Goolam Vahanvati Independent Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19c24fd0-b0f3-4d1b-ab03-46a6cb3719bf.pdf",
            "news_date": "2025-08-28 22:07:50"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Voting Results and Scrutinizer Report of 47th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f0ce8cb-c81b-481b-b402-58d5a04cc184.pdf",
            "news_date": "2025-08-28 22:02:33"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of 47th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90e9cc19-58a0-4a92-b34a-0ac4487631f1.pdf",
            "news_date": "2025-08-28 21:57:44"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "gland Pharma receives approval from USFDA for Vasopressin 5% Dextrose injection USP (RTU vial)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=958f10ef-9dce-42d9-a092-9768e79af9fd.pdf",
            "news_date": "2025-08-26 11:56:30"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meet intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=700a8b0d-cf1c-4989-83b8-dc29ea5e8b20.pdf",
            "news_date": "2025-08-25 15:06:40"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Investor Meets",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44ed2572-6b2d-4064-8019-3efe422e8b0f.pdf",
            "news_date": "2025-08-18 21:52:29"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c279d927-e9f4-4f0f-8bc0-2fee2691c596.pdf",
            "news_date": "2025-08-13 14:57:57"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Schedule of Analyst/Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=096a66a5-fad1-4497-bc5b-36720b1fcf54.pdf",
            "news_date": "2025-08-12 13:04:58"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08dc124a-ba52-450b-916d-b9563aa956b7.pdf",
            "news_date": "2025-08-12 12:57:37"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=821c1633-597e-4b3f-bb2f-499188d0bc37.pdf",
            "news_date": "2025-08-12 12:47:24"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1FY26 Earnings Call Transcript",
            "news_id": "4a690e59-53c9-47ad-9938-c11752bf4a3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=521fa767-e46d-43a5-9df7-582e1a2e5c5c.pdf",
            "news_date": "2025-08-11 17:47:17",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=521fa767-e46d-43a5-9df7-582e1a2e5c5c.pdf",
            "news_date": "2025-08-11 17:47:17"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3A884BE7_B98E_4F15_8B1F_742B686355E5_134242.pdf",
            "news_date": "2025-08-08 13:42:53"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of News paper publication on Q1FY26 Unaudited Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e83aff-afd1-4824-ba86-fc39058e0761.pdf",
            "news_date": "2025-08-06 14:28:27"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings call recording of the Q1FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01e6417b-e31d-405c-8063-4bdbe1c26cea.pdf",
            "news_date": "2025-08-05 21:50:53"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Q1FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0970f67b-9484-45d5-ad65-974d4bf47f7b.pdf",
            "news_date": "2025-08-05 16:44:00"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY26 Financial Results",
            "news_id": "3b8972a6-7a58-4c8c-8591-c443bee6af87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4e532e4-80dd-4d42-a96e-b9c7adccfe7a.pdf",
            "news_date": "2025-08-05 16:37:29",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY26 Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4e532e4-80dd-4d42-a96e-b9c7adccfe7a.pdf",
            "news_date": "2025-08-05 16:37:29"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Submission Of Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Declaration of Unaudited Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd863b7e-cd37-4574-9773-3a7983c0d377.pdf",
            "news_date": "2025-08-05 16:31:49"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended June 30 2025",
            "news_id": "8ed2eb28-1807-41ed-83db-412e75888644",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee44c072-4ee8-4c49-8667-ada77a9b3440.pdf",
            "news_date": "2025-08-05 16:25:50",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee44c072-4ee8-4c49-8667-ada77a9b3440.pdf",
            "news_date": "2025-08-05 16:25:50"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Post Notice Dispatch Paper Add",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffb55d4f-4498-4ba7-a520-b1a9c967ec30.pdf",
            "news_date": "2025-08-01 15:38:46"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "Response to Exchange Clarification sought",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aa99242-d8ac-43b8-9557-3cec251b5904.pdf",
            "news_date": "2025-08-01 15:00:23"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Gland Pharma Ltd",
            "news_body": "The Exchange has sought clarification from Gland Pharma Ltd on August 1 2025 with reference to news appeared in https://www.moneycontrol.com dated August 1 2025 quoting \"Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices\" <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-08-01 13:29:27"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "BRSR Report for the financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44acd327-2dbb-42ea-833b-f988fdbf1206.pdf",
            "news_date": "2025-07-31 13:33:54"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 47Th AGM Of Gland Pharma Limited",
            "news_body": "Notice of 47th AGM of Gland Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c8c1ac1-fdb5-488e-a847-bdf16d6e59a8.pdf",
            "news_date": "2025-07-31 13:23:34"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the Financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2c13564-f778-4289-b41d-f77fa88c1c3b.pdf",
            "news_date": "2025-07-31 13:18:53"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of News paper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=380a11b8-cd98-456c-83ac-cf4c43b64bee.pdf",
            "news_date": "2025-07-22 14:47:00"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Schedule of Earnings Call on August 5 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a3e9eb0-ca88-4e8b-baa2-822fd67f9c72.pdf",
            "news_date": "2025-07-21 17:28:22"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Declaration Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve standalone and consolidated financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd3a0b20-7bd1-493f-b57b-b1cb981594fe.pdf",
            "news_date": "2025-07-21 17:23:48"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Gland Pharma Receives GMP Compliance Certificate From The Danish Medicines Agency For Aseptically Prepared Powder For Injection Infusion And Inhalation",
            "news_body": "Gland Pharma receives GMP Compliance Certificate from the Danish Medicines Agency for aseptically prepared Powder for injection infusion and inhalation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=230ce8ee-be92-43f8-ae3f-49dfbcb2f002.pdf",
            "news_date": "2025-07-11 16:02:05"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63c7e6ae-c87a-4d6c-ac9a-4b29574da9b0.pdf",
            "news_date": "2025-07-11 15:57:09"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Stock Options Under Gland Pharma Employee Stock Option Scheme 2025",
            "news_body": "Grant of Stock Options under Gland Pharma Employee Stock Option Scheme Scheme 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea5628b9-e059-4cfc-a176-8f42964b3cf8.pdf",
            "news_date": "2025-07-03 17:55:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69b0489e-dc04-4039-ad64-85cb41a2d0fd.pdf",
            "news_date": "2025-06-27 12:51:24"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of EIR From US FDA For Companys JNPC Facility Visakhapatnam",
            "news_body": "Receipt of EIR from US FDA for Companys JNPC Facility Visakhapatnam",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c790f5b-9da5-442a-8497-87f70ff20573.pdf",
            "news_date": "2025-06-24 10:39:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Analyst/Investor Meet scheduled on June 26 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09cd5ba6-bcb5-496e-a23d-d5ba3393b966.pdf",
            "news_date": "2025-06-23 21:04:06"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Schedule of Investor Meet on June 24 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64fad3fd-105c-4212-89f8-1df5bc7e3797.pdf",
            "news_date": "2025-06-19 17:26:51"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding the Investor meets scheduled on June 18 19 and 20.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b94d40a0-d4cd-42d2-97c2-3fa13dc22e47.pdf",
            "news_date": "2025-06-13 12:31:57"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Investor Conference on June 12 and June 13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f49f9b55-9e71-4a66-8412-11a70d767d3b.pdf",
            "news_date": "2025-06-09 15:49:59"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On ANSM Inspection At Cenexis Fontenay Manufacturing Facility",
            "news_body": "Update on ANSM Inspection at Cenexis Fontenay Manufacturing Facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b35663a3-62ac-42ce-9e17-25002864c3ce.pdf",
            "news_date": "2025-06-04 18:57:51"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval from USFDA for Angiotensin II Acetate Injection 2.5 mg/mL",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb76bf39-2f7c-4de4-b048-8c9e90a700da.pdf",
            "news_date": "2025-06-04 08:16:59"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Investor Meet on June 06 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79a89cc7-2250-4906-ae3c-8915481710c0.pdf",
            "news_date": "2025-06-03 16:59:27"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Investor Meet on June 05 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4fc324-7141-4577-b600-03725305401d.pdf",
            "news_date": "2025-06-02 20:57:53"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ending March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d09963c-15a9-402e-a9da-57c311f9daed.pdf",
            "news_date": "2025-05-27 15:25:47"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Earnings Call held on May 20 2025",
            "news_id": "6a90c424-ee0c-43f0-af15-69fa90a29a05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6c12ae4-ea0b-4fd5-9091-a9bf276115fb.pdf",
            "news_date": "2025-05-27 12:47:11",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript for the Earnings Call held on May 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6c12ae4-ea0b-4fd5-9091-a9bf276115fb.pdf",
            "news_date": "2025-05-27 12:47:11"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Stock Options (Grant I) Under Gland Pharma Employee Stock Option Scheme 2025 (ESOP 2025 Or Scheme)",
            "news_body": "Intimation regarding approval of ESOP Grant I under Gland Pharma Employee Stock option Scheme 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38fa5042-fece-4aa9-a2a1-d0ebb12a7ccd.pdf",
            "news_date": "2025-05-22 20:58:18"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Q4FY25 Audited Financial Results News Paper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f9032a-1a38-4f38-b67f-6d59342bc50f.pdf",
            "news_date": "2025-05-21 14:45:11"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings Call Audio Recording",
            "news_id": "5f21cc1e-c481-47b9-b046-a79715282e90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13dadea-3f4f-49c3-80be-1480764dbef3.pdf",
            "news_date": "2025-05-20 22:14:25",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings Call Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13dadea-3f4f-49c3-80be-1480764dbef3.pdf",
            "news_date": "2025-05-20 22:14:25"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e0cac29-230e-4a5e-8581-4252915f86ac.pdf",
            "news_date": "2025-05-20 17:36:04"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "The 47Th AGM Of The Company Is Scheduled To Be Held On Thursday August 28 2025",
            "news_body": "The 47th AGM of the Company is scheduled to be held on Thursday August 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb10ea64-ac93-4e25-b417-4f1271a89362.pdf",
            "news_date": "2025-05-20 17:30:31"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Board Fixes August 14 2025 As The Record Date For Final Dividend",
            "news_body": "Board fixes August 14 2025 as the Record Date for final dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c25278a-575a-47c7-9827-a9f22c9a5363.pdf",
            "news_date": "2025-05-20 17:22:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Recommendation of Final Dividend of Rs. 18/- per share for the Financial Year 2024-25; subject to approval of shareholders in the 47th AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56c88479-8fd5-4f1a-87d1-ed2b7af54ca9.pdf",
            "news_date": "2025-05-20 17:17:13"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on Q4FY25 Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7d65b21-edf6-4146-ac5e-27756fadffa5.pdf",
            "news_date": "2025-05-20 17:11:43"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q4FY25",
            "news_id": "6e08b7ed-372c-479c-acbe-d59462424072",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73d15ea-c7e4-49eb-9235-857aea24cf30.pdf",
            "news_date": "2025-05-20 17:09:36",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q4FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73d15ea-c7e4-49eb-9235-857aea24cf30.pdf",
            "news_date": "2025-05-20 17:09:36"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - May 20 2025",
            "news_body": "Outcome of Board Meeting - May 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7983844-f77a-4049-bd37-bbfde669dd30.pdf",
            "news_date": "2025-05-20 17:06:08"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investor Meet Intimation - 23052025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0301fc5-676c-4d5d-82b2-b81b806e2fa3.pdf",
            "news_date": "2025-05-20 13:50:17"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESOP Compensation Committee Meeting",
            "news_body": "Intimation regarding ESOP Compensation Committee Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f471e90e-ce92-4032-81e9-84fa0c7fa2bb.pdf",
            "news_date": "2025-05-18 19:19:40"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation regarding Earnings Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a9295a4-a95e-40f0-ae36-5f8f17d246a3.pdf",
            "news_date": "2025-05-06 17:09:35"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025 And Recommend The Payment Of Final Dividend For FY 2024-25",
            "news_body": "Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025 and recommend the payment of Final Dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc0a87d3-6443-4d9b-8907-2cc2874ff13d.pdf",
            "news_date": "2025-05-06 17:02:12"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval from USFDA for Latanoprostene Bunod Opthalmic Solution",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf9ff2e-1601-46c0-bfcc-ebd21f88bcdb.pdf",
            "news_date": "2025-04-30 14:05:10"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Change In Contact Details Of RTA",
            "news_body": "Intimation regarding Change in contact details of RTA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c75557e-1993-4646-87f5-0a8d3ed00980.pdf",
            "news_date": "2025-04-24 13:04:04"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4EEA5C56_BA25_43F8_8E2C_CA49305C7F15_092134.pdf",
            "news_date": "2025-04-16 09:21:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e6cb8d-1c2f-44d6-ba9d-64ed0e7b6ce3.pdf",
            "news_date": "2025-04-10 10:31:58"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Gland Pharma receives approval for Acetaminophen Injection",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac787082-5a93-4a30-86f1-8e7eb4f64664.pdf",
            "news_date": "2025-04-03 11:16:38"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Postal Ballot Results - Scrutinizer Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48cdee69-218d-40de-ad4a-e0208f98fbb8.pdf",
            "news_date": "2025-03-31 15:26:36"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Postal Ballot Voting Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8371615-ac77-4956-b3f3-61bf8f63f21e.pdf",
            "news_date": "2025-03-31 15:24:26"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading Window Closure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6dca3996-e82e-4aa1-9451-89918d0b1097.pdf",
            "news_date": "2025-03-28 18:23:12"
        },
        {
            "co_code": 14546,
            "bse_code": 543245,
            "isin": "INE068V01023",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f7589e1-9921-405a-b305-72708f52a222.pdf",
            "news_date": "2025-03-24 15:06:25"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "8cfbe9df-3e18-4cc3-a803-1056b0eac65a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f76772f-96b3-4b3b-a419-985c7474a147.pdf",
            "news_date": "2025-02-10 18:41:03",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on Q3FY25 Financial Results",
            "news_id": "f915cd46-bbf8-404b-8338-47836bc41b2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f364bfc8-c127-40b4-a9a1-280ae7101498.pdf",
            "news_date": "2025-02-03 17:41:28",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the Quarter ended December 31 2024",
            "news_id": "69cd5fc2-4a31-4acc-ad12-82e5559ad6c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cdd8edb-0ae7-45a7-adaf-adc738b16a65.pdf",
            "news_date": "2025-02-03 17:22:38",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript - November 04, 2024",
            "news_id": "065daa5e-77f7-438c-aea1-2eb6244ed3ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f92d2fd-f0bf-40fe-b4bf-297d87627c5f.pdf",
            "news_date": "2024-11-11 14:15:14",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY25 Financial Results",
            "news_id": "600eca26-eccc-4b5f-a665-16566f819f68",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33b7fb4d-ac78-47a5-9afb-926ea738b5fc.pdf",
            "news_date": "2024-11-04 17:48:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "693b5c3d-476f-4889-8386-ee1112c3f481",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b216c63-706e-4285-84b9-7b82bde14ea2.pdf",
            "news_date": "2024-11-04 17:38:04",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on August 06, 2024",
            "news_id": "8669762b-8afc-4936-b762-e9dd46f91cc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8f3b7a8-e203-4f66-9959-14e90a750195.pdf",
            "news_date": "2024-08-12 16:59:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1 FY25",
            "news_id": "e71e6215-cd64-4c9b-95be-bd3565d6c472",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7325620-6f8b-4ded-a826-2765c084a968.pdf",
            "news_date": "2024-08-06 17:17:18",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Q1 FY25",
            "news_body": "Unaudited Financial Results for Q1 FY25",
            "news_id": "5d42ba17-fc9e-46df-ab52-895ee7e8bd8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5a45625-b123-4584-aba5-b026124a87cb.pdf",
            "news_date": "2024-08-06 17:01:20",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Conference Call held on May 22, 2024",
            "news_id": "1fc10713-db14-4cb1-8950-2dc4d2ac32d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25470e59-a9c1-41ed-b6e1-31a07154e694.pdf",
            "news_date": "2024-05-29 15:15:41",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q4FY24",
            "news_id": "519d5840-a8b9-4459-9281-60e01a739377",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c27b6df-3aa7-43c9-8b5e-74c3bb1c1558.pdf",
            "news_date": "2024-05-22 17:54:59",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Financial Year Ended March 31, 2024",
            "news_body": "Audited Financial Results for the Financial Year ended March 31, 2024",
            "news_id": "e07f7a4c-3348-4fa3-8c64-954a4638bcb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b23900e-1d06-4816-8fce-7568a8d59331.pdf",
            "news_date": "2024-05-22 17:41:36",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the call held on 14.02.2024",
            "news_id": "f54fc98c-634f-40b1-94cd-022d310d0f11",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f784519-61aa-4f11-b6ee-ac6358814cc2.pdf",
            "news_date": "2024-02-21 12:27:45",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earning Conference call held on 14.02.2024",
            "news_id": "0f2f3981-e85e-48d5-9eee-fd4918b40a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e41cabc-7012-440e-8542-05556ea7b46b.pdf",
            "news_date": "2024-02-14 21:49:28",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY24 Financial Results",
            "news_id": "1292eda3-53d0-4346-87e0-fd2d44dd038f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b845236-a32e-46cd-a11c-fa00559b0e17.pdf",
            "news_date": "2024-02-14 16:39:54",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Board Of Directors At Its Meeting Held On February 14, 2024 Has Inter-Alia Approved The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial results for the quarter and nine months ended 31.12.2023",
            "news_id": "fcd1eba0-e6ba-4d58-a209-30c207e40e82",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c062461-ac1d-4c12-814a-2da18da79346.pdf",
            "news_date": "2024-02-14 16:19:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter  and half year ended September  30, 2023",
            "news_id": "57d7f91f-6f69-42aa-ae94-0084636cadad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac766eae-723c-4bdc-8051-787ba2f9fd59.pdf",
            "news_date": "2023-11-06 20:57:20",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY24 Financial Results",
            "news_id": "790aad1e-9935-4d58-b151-0a14d3048527",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a90919c9-0e22-49f3-8e75-c935507dc43e.pdf",
            "news_date": "2023-11-06 16:27:56",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Unaudited financial results of the Company for the quarter and half year ended September 30, 2023",
            "news_id": "7fb0800b-f0c3-4299-8847-72c9561e7525",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557c863e-7890-4cb5-a4cb-8ffedf0e4195.pdf",
            "news_date": "2023-11-06 16:18:27",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q1FY24",
            "news_id": "9f05bf42-73c5-44f3-8211-0de57feccece",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3df6e387-54da-441e-b2d3-28836c8351fd.pdf",
            "news_date": "2023-08-11 19:00:09",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter ended June 30, 2023",
            "news_id": "56ba488b-7e24-47a9-b5b9-b6d74669b7e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=637ee07b-6b74-4bc8-9ef8-1e740186c675.pdf",
            "news_date": "2023-08-07 23:10:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY24 Financial Results",
            "news_id": "0fb6bec3-b0c8-4588-a105-10c6d4d0a357",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20d97f9a-7c32-4c82-bb6e-031381fa5439.pdf",
            "news_date": "2023-08-07 16:46:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2023.",
            "news_body": "Unaudited financial results of the Company for the quarter ended June 30, 2023",
            "news_id": "1ec2d2e9-7ef7-4177-beda-0c7f7c377c4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56b51db5-ae66-476e-a7cc-221b7f8a49da.pdf",
            "news_date": "2023-08-07 16:26:21",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "The Board of Directors at its meeting held on August 07, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2023.",
            "news_id": "ccf1854c-6f85-4bd3-867a-130a72ca5fa8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa524c93-5353-498e-bd97-bf551f7948b9.pdf",
            "news_date": "2023-08-07 16:18:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q4FY23",
            "news_id": "b403ce04-22a5-4fef-b0d4-fd445f55d23a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11224d20-b20f-4256-9061-58fc482f87b7.pdf",
            "news_date": "2023-05-25 21:29:01",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and financial year ended March 31, 2023",
            "news_id": "7de1e17a-b1e4-4822-a909-2e41aa1b2a0f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=710703c1-636c-4e6e-a93b-eff81e86a43a.pdf",
            "news_date": "2023-05-18 22:18:12",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Revised Outcome",
            "news_body": "Revised outcome-The unsigned covering letter was filed inadvertently earlier.",
            "news_id": "54c0f5e0-0909-4064-bea2-8034dc59fcb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13af0ee-b20b-4d9b-98c7-eab8fce0c06b.pdf",
            "news_date": "2023-05-18 17:59:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY23 Financial Results",
            "news_id": "16e97786-4181-46f2-8630-17ec2385a907",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=824cdf8e-8981-46ab-9d88-e138fc5f5861.pdf",
            "news_date": "2023-05-18 17:52:40",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023.<BR> <BR> The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023.<BR>",
            "news_id": "ae32506a-dfac-453e-b99e-dabe675a3a8a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1153f05-02a1-4f51-af6a-bb338b0a23b6.pdf",
            "news_date": "2023-05-18 17:40:55",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2023<BR>",
            "news_id": "56b5710f-292d-4ced-97c6-f65272df3730",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e0d1690-1291-4b94-bd21-d4235128d94c.pdf",
            "news_date": "2023-05-18 17:37:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023.<BR> <BR> The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023.<BR> <BR>",
            "news_id": "b01505af-a270-4756-9ce1-8de854c71ca2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ee6c137-cca7-454e-880e-d3038891fa55.pdf",
            "news_date": "2023-05-18 17:26:07",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q3FY23",
            "news_id": "858c4368-fd53-4247-ac8d-b0e517f9f3b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd9de941-7b77-4fe6-b4ed-04c68faf369b.pdf",
            "news_date": "2023-01-31 21:57:33",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and nine months ended December 31, 2022",
            "news_id": "d5b6ab2b-75ed-4798-9bd0-99548bbacba1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=128803ed-675e-42de-8661-a7fca66f2f42.pdf",
            "news_date": "2023-01-23 22:29:19",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q3FY23 Financial Results",
            "news_id": "48ea7ff7-1fcb-419e-9bf0-133c12360cf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1405d0e-3da2-454a-9024-1a71236c98eb.pdf",
            "news_date": "2023-01-23 16:37:38",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "The Board of Directors at its meeting held on January 23, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "0cf55041-7c25-4f11-aaf7-a50f50987755",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f04f5168-a49f-40cc-8d63-85ce70badcd2.pdf",
            "news_date": "2023-01-23 16:21:43",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "The Board of Directors at its meeting held on January 23, 2023 has inter-alia approved the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "2783be80-6551-4ef9-95f1-01ec421cd186",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53e19a5e-2fcd-4ec8-aa2b-ce71ac1cdcd0.pdf",
            "news_date": "2023-01-23 16:12:46",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on the Proposed Acquisition of Cenexi Group",
            "news_id": "735e7349-eb75-42de-affd-8b0ae4814fbe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31782c6b-3d40-4053-9f1e-dd2d7c34f777.pdf",
            "news_date": "2022-11-29 18:01:10",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 30Th September 2022",
            "news_body": "Related Party Transactions for the half year ended 30th September 2022",
            "news_id": "e8ff4e56-3926-460d-ad4d-06cf61787b51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f18e68e9-e918-402c-88f3-659fa013883e.pdf",
            "news_date": "2022-11-04 17:44:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q2FY23",
            "news_id": "c258535c-436d-4b0c-9ba0-5700f6713ad4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=922c340a-a306-4b7b-bacd-a86c5b6c899e.pdf",
            "news_date": "2022-11-02 21:45:15",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and half year ended September 30, 2022",
            "news_id": "e68e503f-f950-4947-8c3a-28ac6509390a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7623d361-16cd-46b6-aefd-c32e22e4647a.pdf",
            "news_date": "2022-10-26 22:42:48",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q2FY23 Financial Results",
            "news_id": "2879627c-ad2d-418f-af39-d570bef92951",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d5a06b-5023-4642-8470-e1de0dfaf968.pdf",
            "news_date": "2022-10-26 15:59:21",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September  30, 2022",
            "news_body": "The Board of Directors at its meeting held on October 26, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "f8e6e718-d22c-439e-8dd2-3bef6109dc65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e3b5a1f-9049-4cb3-94d2-d66c62db6093.pdf",
            "news_date": "2022-10-26 15:46:16",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q1FY23 Financial Results",
            "news_id": "44e96062-a82f-4d01-8272-ae741e8aecb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=144ac587-0259-42d8-8200-ba44f991bb21.pdf",
            "news_date": "2022-07-20 16:13:53",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors at its meeting held on July 20, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2022.",
            "news_id": "9f2d77ed-ee3d-4d00-b069-6e706a0b365e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fa95de0-f673-4492-81e3-23df7f1c2658.pdf",
            "news_date": "2022-07-20 16:02:17",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "The Board of Directors at its meeting held on July 20, 2022 has inter-alia approved the Unaudited financial results of the Company for the quarter ended June 30, 2022.",
            "news_id": "38a37999-f5d2-435a-9eee-2556e2b7a116",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7666e884-216a-4382-b0f7-6c125a747836.pdf",
            "news_date": "2022-07-20 15:59:56",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 31St March 2022",
            "news_body": "Related Party Transactions for the Half Year Ended 31st March 2022",
            "news_id": "85e55c08-d00d-4bf2-b72e-881c57f5ea50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361e03dc-86ff-400f-9296-3242dfe3f428.pdf",
            "news_date": "2022-05-31 18:08:45",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q4FY22",
            "news_id": "025d9573-2b15-4fac-8c72-ae5cd50c8fb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07416be0-99f7-4305-bcc0-b79589711c82.pdf",
            "news_date": "2022-05-26 18:01:06",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call for the quarter and year ended March 31, 2022",
            "news_id": "ae297abf-9bcb-4aa4-bc91-c5e71cc4a062",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbc45d49-e95d-45cc-bf10-d6578302a261.pdf",
            "news_date": "2022-05-19 23:31:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY22 Financial Results",
            "news_id": "7f0e2ade-d50e-4df5-92c9-63c7603daf85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a167e0d-db79-4120-8686-c1bd05579026.pdf",
            "news_date": "2022-05-19 16:52:00",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March 31, 2022.",
            "news_body": "Audited Financial Results for the year ended March 31, 2022.",
            "news_id": "db9b405b-ad6b-4445-91f6-c9a1e6587de2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce119c1c-9a1c-41b5-9176-667c5ce77368.pdf",
            "news_date": "2022-05-19 16:22:34",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on May 19, 2022 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2022.<BR> <BR> The 44th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Tuesday, August 30, 2022.",
            "news_id": "d434fec6-6b6c-4551-be06-2a361280ca66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d65b14c-2f49-4770-b8f0-6a23f9ffbbc1.pdf",
            "news_date": "2022-05-19 16:08:44",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q3FY22",
            "news_id": "6341e99e-166c-48be-991a-f1d3255f611c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b678d18-20be-49fd-bdc8-02155d6aa3d2.pdf",
            "news_date": "2022-01-28 20:17:09",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter and nine months ended December 31, 2021",
            "news_id": "f6360724-6d27-4a77-8cdb-b830aeb2b74f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4abfde11-506c-405b-99d5-cc29a55d9dff.pdf",
            "news_date": "2022-01-21 15:55:02",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors at its meeting held on January 21, 2022 has inter-alia approved the Unaudited financial results of the  Company for the quarter and nine months ended December 31, 2021",
            "news_id": "d2372692-f4ca-4515-81c4-2271596efcbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e54ab449-93ea-4983-8a96-5845100d604d.pdf",
            "news_date": "2022-01-21 15:40:07",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript for Q2FY22",
            "news_id": "3641537d-28ff-42ab-a54e-c2e2fb2590d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bebff46a-2a9b-491c-9b17-48218cfec14c.pdf",
            "news_date": "2021-11-03 11:31:34",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter and half year ended September 30, 2021",
            "news_id": "8dcf3c20-31af-4f84-876b-49a3a8e437b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f6bb216-e6c2-40bd-a839-c92d69945d1c.pdf",
            "news_date": "2021-10-22 15:47:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors at its meeting held on October 22, 2021 has inter- alia approved the Unaudited Financial Results for the Quarter and half year ended September 30, 2021",
            "news_id": "5c63db54-b793-4259-8e25-a19491e7f99b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e65b3e-f1a2-4322-9cd7-97e91f8116b3.pdf",
            "news_date": "2021-10-22 15:44:35",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the CEO track forum - Motilal Oswal 17th Annual Global Investor Conference to be held on September 8, 2021",
            "news_id": "fb660763-637a-42fd-846a-6f308daa2a70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fe678c2-77dd-4f17-b612-c7cbc6faa301.pdf",
            "news_date": "2021-09-07 20:27:16",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript for Q1FY22",
            "news_id": "ff36acdf-6d9b-4f39-9e61-735cdc0ac0a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8eec656a-b4ce-46cf-9490-c09161cfcd36.pdf",
            "news_date": "2021-07-31 17:04:22",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation on the Unaudited Financial Results for the Quarter ended June 30, 2021",
            "news_id": "778687ac-585a-45f5-8aa8-f15fa20166f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02684a78-2997-41a0-b081-49741db48986.pdf",
            "news_date": "2021-07-21 16:36:59",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "The Board of  Directors at its meeting held on July 21, 2021 has inter- alia approved the Unaudited Financial Results of the Company for the Quarter ended June 30, 2021",
            "news_id": "4d85fdd1-5ecf-4294-826b-3b899df73288",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af54ff54-0b11-47ce-bd30-5e641b86eff5.pdf",
            "news_date": "2021-07-21 16:13:46",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript- Q4FY21",
            "news_id": "cc3d2374-cb00-4cb8-9ce0-11194ec23bd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42607429-aaab-4cdc-95c8-5b21bcffc8c4.pdf",
            "news_date": "2021-05-21 10:01:08",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Q4FY21 Financial Results",
            "news_id": "cc0ce90b-5bb3-4a36-a41a-c2bae703fafd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77756a70-adf1-450d-bbbf-a067eeb45bf6.pdf",
            "news_date": "2021-05-17 17:01:29",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAND",
            "disp": "Gland Pharma",
            "bse_code": 543245,
            "isin": "INE068V01023",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "The Board of Directors of Gland Pharma Limited (the 'Company') at its Meeting held today, i.e. Monday, May 17, 2021 has inter-alia considered and approved Audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2021",
            "news_id": "70e059e2-a2b0-4d7a-8d40-91c22af385a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adb8d865-be96-4e08-b661-942f98289b1a.pdf",
            "news_date": "2021-05-17 16:14:58",
            "seo": "gland-pharma-ltd",
            "ltp": 1868.4,
            "ch": -17.09999999999991,
            "pch": -0.9069212410501145,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1186,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}